Browse by Journal Title

Article

Rationale and design of the Prevention of Cardiac Dysfunction During an Adjuvant Breast Cancer Therapy (PRADA) Trial.
Heck, S.L., Gulati, G., Ree, A.H., Schulz-Menger, J., Gravdehaug, B., Rosjo, H., Steine, K., Bratland, A., Hoffmann, P., Geisler, J. and Omland, T.
Cardiology 123 (4): 240-247. 30 November 2012

Local renin-angiotensin systems in cardiovascular tissues: localization and functional role.
Stock, P., Liefeld, L., Paul, M. and Ganten, D.
Cardiology 86 (Suppl.1): 2-8. 1 January 1995

Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
Lindpaintner, K. and Ganten, D.
Cardiology 79 (Suppl 1): 32-44. 1 January 1991

Review

Rosuvastatin - A highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: Review of clinical trial data at 10-40 mg doses in dyslipidemic patients.
Schuster, H.
Cardiology 99 (3): 126-139. June 2003